PhRMA Statement on Bloomberg Article

Washington, D.C. (September 19, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

PhRMA Statement on Avalere Health Analysis on Medicare Part D Premiums

Washington, D.C. (September 25, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on findings from Avalere Health on Medicare Part D premiums:

Speech: John J. Castellani National Press Club Remarks

Remarks
John J. Castellani
President & CEO
Pharmaceutical Research and Manufacturers of America
The National Press Club
Washington, D.C.
Thursday, September 20, 2012

 

Thank you, Keith for that kind introduction. And my thanks to all of you here for joining me this morning.

Researchers and Patient Advocates Honored with PhRMA Award

Washington, D.C. (September 7, 2012)— The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year’s award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer’s disease.

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

Washington, D.C. (June 18, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today:

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

Washington, D.C. (May 24, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:
 

Counterfeit Medicines: Q&A with Pfizer's Chief Security Officer

05.21.12 | By

The editors at The Catalyst recently asked John P. Clark, Vice President and Chief Security Officer, Pfizer Inc., a few questions about being on the front line in the battle against foreign counterfeit medicines. John provided a snapshot of the risks patients could face if the closed U.S. drug supply system were to open up. I urge you take a close look at all the pictures provided by Pfizer Inc.

Speech: 2012 PhRMA Annual Meeting: President's Address

John J. Castellani
President & CEO
Pharmaceutical Research and Manufacturers of America
Annual Meeting Address
Boston, Massachusetts
April 12, 2012

In our industry today, everyone uses familiar words to describe what we do: Innovation, progress, technology, value, science, partnership, solutions, jobs and so many more.

But to resonate, these words must do more than just describe – they must tell our story.

PhRMA Statement on AARP Drug Pricing Report

Washington, D.C. (March 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement:

“AARP has released yet another misleading pricing report that ignores key facts about the marketplace for prescription medicines and paints an inaccurate picture of prescription drug spending in the U.S.

PhRMA Statement on State of the Union

Washington, D.C. (January 24, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani released the following statement in response to the President's State of the Union address:

Pages

Subscribe to RSS - Opinion